Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

76 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Global Collaborations for Cervical Cancer: Can the East-West Alliance Facilitate Treatment for all?
Chopra S, Mittal P, Viswanathan A, Tharavichitkul E, Zubizarreta E, Nout RA, Yap ML, Grover S, Rodin D, Rai B, Gondhowiardjo S, Shrivastava SK. Chopra S, et al. Among authors: tharavichitkul e. Clin Oncol (R Coll Radiol). 2019 Aug;31(8):529-538. doi: 10.1016/j.clon.2019.05.022. Epub 2019 Jun 20. Clin Oncol (R Coll Radiol). 2019. PMID: 31229379 Free PMC article. Review.
A phase II study of oxaliplatin with 5-FU/folinic acid and concomitant radiotherapy as a preoperative treatment in patients with locally advanced rectal cancer.
Chitapanarux I, Chitapanarux T, Tharavichitkul E, Mayurasakorn S, Siriwittayakorn P, Yamada S, Lorvidhaya V. Chitapanarux I, et al. Among authors: tharavichitkul e. Biomed Imaging Interv J. 2011 Oct;7(4):e25. doi: 10.2349/biij.7.4.e25. Epub 2011 Oct 1. Biomed Imaging Interv J. 2011. PMID: 22279502 Free PMC article.
Capecitabine and weekly paclitaxel as first-line therapy in Thai patients with metastatic breast cancer.
Chitapanarux I, Kamnerdsupaphon P, Tharavichitkul E, Lorvidhaya V, Trakultivakorn H, Srisukho S, Somwangprasert A, Watcharachan K, Sukthomya V. Chitapanarux I, et al. Among authors: tharavichitkul e. Asia Pac J Clin Oncol. 2012 Mar;8(1):76-82. doi: 10.1111/j.1743-7563.2011.01467.x. Epub 2012 Jan 12. Asia Pac J Clin Oncol. 2012. PMID: 22369447 Clinical Trial.
A phase II study of docetaxel and carboplatin with concurrent radiation therapy for locally advanced head and neck cancer.
Chitapanarux I, Lorvidhaya V, Tharavichitkul E, Mayurasakorn S, Sittitrai P, Pattarasakulchai T, Tananuwat R, Srivanitchapoom C. Chitapanarux I, et al. Among authors: tharavichitkul e. Auris Nasus Larynx. 2011 Feb;38(1):108-13. doi: 10.1016/j.anl.2010.05.012. Epub 2010 Jun 29. Auris Nasus Larynx. 2011. PMID: 20591592 Clinical Trial.
Can radiographic plain film be used to determine the depth of the tumour bed in the absence of surgical clips for breast boost planning.
Chitapanarux I, Muttarak M, Na-Chiangmai W, Trakultivakorn H, Somwangprasert A, Kamnerdsupaphon P, Tharavichitkul E, Sukthomya V, Lorvidhaya V, Watcharawipha A. Chitapanarux I, et al. Among authors: tharavichitkul e. Biomed Imaging Interv J. 2009 Jul;5(3):e11. doi: 10.2349/biij.5.3.e11. Epub 2009 Jul 1. Biomed Imaging Interv J. 2009. PMID: 21611050 Free PMC article.
Scalp dose analysis for transient and permanent alopecia following conventional cranial irradiation using Image Guided Radiotherapy (IGRT): A prospective study.
Jia-Mahasap B, Nobnop W, Sripan P, Tharavichitkul E, Chakrabandhu S, Klunklin P, Onchan W, Muangwong P, Chitapanarux I. Jia-Mahasap B, et al. Among authors: tharavichitkul e. PLoS One. 2024 Oct 10;19(10):e0311855. doi: 10.1371/journal.pone.0311855. eCollection 2024. PLoS One. 2024. PMID: 39388438 Free PMC article.
The Dose Difference of Dominant Intraprostatic Lesions (DILs) Defined by Magnetic Resonance-Guided and arc-based Intensity Modulated Radiation Therapy (IMRT), and the Association between Dose Difference and Recurrent Prostate Cancer.
Amantakul A, Kanthawang T, Tantraworasin A, Tharavichitkul E. Amantakul A, et al. Among authors: tharavichitkul e. Asian Pac J Cancer Prev. 2024 Sep 1;25(9):3269-3275. doi: 10.31557/APJCP.2024.25.9.3269. Asian Pac J Cancer Prev. 2024. PMID: 39342606 Free PMC article.
Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 trial.
Lorusso D, Xiang Y, Hasegawa K, Scambia G, Leiva M, Ramos-Elias P, Acevedo A, Cvek J, Randall L, Pereira de Santana Gomes AJ, Contreras Mejía F, Helpman L, Akıllı H, Lee JY, Saevets V, Zagouri F, Gilbert L, Sehouli J, Tharavichitkul E, Lindemann K, Colombo N, Chang CL, Bednarikova M, Zhu H, Oaknin A, Christiaens M, Petru E, Usami T, Liu P, Yamada K, Toker S, Keefe SM, Pignata S, Duska LR; ENGOT-cx11/GOG-3047/KEYNOTE-A18 investigators. Lorusso D, et al. Among authors: tharavichitkul e. Lancet. 2024 Oct 5;404(10460):1321-1332. doi: 10.1016/S0140-6736(24)01808-7. Epub 2024 Sep 14. Lancet. 2024. PMID: 39288779 Clinical Trial.
76 results